A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2
- 1 May 1990
- journal article
- Published by Springer Nature in Nature
- Vol. 345 (6270) , 41-46
- https://doi.org/10.1038/345041a0
Abstract
Adhesion measurements between CD8 and 48 point mutants of HLA-A2.1 show that the CD8 alpha-chain binds to the alpha 3 domain of HLA-A2.1. Three clusters of alpha 3 residues contribute to the binding, with an exposed, negatively charged loop (residues 223-229) playing a dominant role. CD8 binding correlates with cytotoxic T-cell recognition and sensitivity to inhibition by anti-CD8 antibodies. Impaired alloreactive T-cell recognition of an HLA-A2.1 mutant with reduced affinity for CD8 is not restored by functional CD8 binding sites on an antigenically irrelevant class I molecule. Therefore, complexes of CD8 and the T-cell receptor bound to the same class I major histocompatibility complex molecule seem to be necessary for T-cell activation.Keywords
This publication has 49 references indexed in Scilit:
- STRUCTURE, FUNCTION, AND DIVERSITY OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULESAnnual Review of Biochemistry, 1990
- Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptorNature, 1989
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lckCell, 1988
- T-cell antigen receptor genes and T-cell recognitionNature, 1988
- Evidence for specific association between class I major histocompatibility antigens and the CD8 molecules of human suppressor/cytotoxic cellsCell, 1988
- A single amino acid substitution in the alpha 3 domain of an H-2 class I molecule abrogates reactivity with CTL.The Journal of Experimental Medicine, 1987
- Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule.The Journal of Experimental Medicine, 1985
- Perturbation of the T4 molecule transmits a negative signal to T cells.The Journal of Experimental Medicine, 1985
- Monoclonal anti-Lyt-2.2 antibody blocks lectin-dependent cellular cytotoxicity of H-2-negative target cells.The Journal of Experimental Medicine, 1984